Results 61 to 70 of about 204,846 (354)

Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder

open access: yesFrontiers in Immunology, 2021
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease of the central nervous system (CNS), characterized by pathogenic, complement-activating autoantibodies against the main water channel in the CNS, aquaporin 4 (AQP4 ...
Barbara Uzonyi   +17 more
doaj   +1 more source

Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.

open access: yesBrain : a journal of neurology, 2019
Neuromyelitis optica spectrum disorders (NMOSD) constitute rare autoimmune disorders of the CNS that are primarily characterized by severe inflammation of the spinal cord and optic nerve. Approximately 75% of NMOSD patients harbour circulating pathogenic
E. Cotzomi   +15 more
semanticscholar   +1 more source

Clinical and autoantibody phenotypes of juvenile dermatomyositis

open access: yes, 2022
Juvenile dermatomyositis (JDM) is a heterogeneous autoimmune inflammatory myositis with symmetrical proximal muscle weakness and a characteristic rash. Juvenile dermatomyositis is characterized by variable presentation and phenotypes.
Iryna Yuryk   +5 more
core   +1 more source

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

open access: yesAnnals of the Rheumatic Diseases, 2019
Objectives Idiopathic inflammatory myopathies (IIM) are a spectrum of rare autoimmune diseases characterised clinically by muscle weakness and heterogeneous systemic organ involvement.
S. Rothwell   +32 more
semanticscholar   +1 more source

Participant characteristics and autoantibody status.

open access: yes, 2016
Participant characteristics and autoantibody status.
Helen Schuilenburg (5928)   +37 more
core   +1 more source

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

open access: yesNature Communications, 2018
Autoantibodies have been associated with autoimmune diseases. However, studies have identified autoantibodies in healthy donors (HD) who do not develop autoimmune disorders.
O. Cabral-Marques   +35 more
semanticscholar   +1 more source

Distinct autoantibody profiles across checkpoint inhibitor types and toxicities [PDF]

open access: yes
Immune checkpoint inhibitors (ICI) are increasingly used in combination. To understand the effects of different ICI categories, we characterized changes in circulating autoantibodies in patients enrolled in the E4412 trial (NCT01896999) of brentuximab ...
Yang Xie   +32 more
core   +1 more source

Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus. [PDF]

open access: yesPLoS ONE, 2015
Systemic lupus erythematosus (SLE) is characterized by the development of autoantibodies associated with specific clinical manifestations. Previous studies have shown an association between differential DNA methylation and SLE susceptibility, but have ...
Sharon A Chung   +6 more
doaj   +1 more source

Low T-cell reactivity to TDP-43 peptides in ALS

open access: yesFrontiers in Immunology, 2023
BackgroundDysregulation of the immune system in amyotrophic lateral sclerosis (ALS) includes changes in T-cells composition and infiltration of T cells in the brain and spinal cord.
Swetha Ramachandran   +10 more
doaj   +1 more source

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

open access: yesCancer immunology research, 2018
Ipilimumab induced autoantibodies in a fifth of melanoma patients. Patients who developed autoantibodies, especially thyroid autoantibodies, experienced more irAEs and had a survival and response benefit, suggesting that breaking of B-cell tolerance ...
E. D. de Moel   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy